drug approval

Shilpa Secures SEC, CDSCO Approval for New IND Tablets in NAFLD

Shilpa Medicare has received approval from India’s top drug authorities to move forward with its new IND - Nor-Ursodeoxycholic Acid (500 mg).

Trump Discusses Issues With Drugmakers

A New Pathway

UK Health Agency Blesses Merck Cancer Drug

Amgen Gets Nod for New Cholesterol Drug

FDA Approves new Boehringer COPD Drug

EU Approves Sales of Sanofi’s New Diabetes Drug

Japan’s Eisai Gets EU Nod for Thyroid Cancer Drug

New J&J Anti-depressant Related to "Special K" Party Drug

Teva Pharmaceutical Banks on Thrice-weekly Copaxone

AbbVie Delivers on Scorching Humira Drug Sales Growth

Roche to Release All Tamiflu Drug Data

Biogen Wins EU Backing for Big New MS Drug Hope

Antibiotics Crisis Prompts Rethink on Risks, Rewards

Switzerland's Roche Pledges to Open Up Access to Drug Data

FDA Halts Trials of Amgen Drug in Children, Cites Death

Slow Approvals Put India's Drug Trials Industry at Risk

Drug Industry Bets on New Blockbusters in 2013

Merck Steers Doctors Away from HDL Cholesterol Drug

US FDA New Drug Approvals Hit 16-Year High in 2012

FDA Approves Bristol Myers, Pfizer's Anti-Clotting Drug Eliquis

Number of New Drugs Picks Up in Europe and U.S.

Lundbeck's Alcohol Dependency Drug Gets EU Green Light

EU Agency Rejects Sanofi, Isis Cholesterol Drug

Novo Bets on High-Price Niche for Obesity Drug

Drug Industry Treading Water on R&D Productivity

U.S. Supreme Court to Review Lawsuits over Flaws in Generic Drugs

Europe Approves High-Price Gene Therapy

FDA Reviewers Spot Safety Concerns With Sanofi, Isis Lipid Drug

Novartis Drug Afinitor Gets EU Nod for Breast Cancer

U.S. Health Advisers Back Two New Eye Treatments

EU Set to Simplify Clinical Trial Rules

K-V Sues FDA over Makena in Fight for Survival